Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).
Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, Jougla E, Semaille C, Morlat P, Salmon D, Cacoub P, Chêne G; ANRS EN19 Mortalité Study Group and Mortavic1. Lewden C, et al. Among authors: morlat p. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590-8. doi: 10.1097/QAI.0b013e31817efb54. J Acquir Immune Defic Syndr. 2008. PMID: 18645512 Free article.
[Causes of death in HIV-infected French drug users, 1995-2000].
Lewden C, Bonnet F, Bevilacqua S, Heripret L, May T, Morlat P, Jougla E, Dabis F, Chêne G, Salmon D; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine; Groupe "Mortalité 2000". Lewden C, et al. Among authors: morlat p. Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S4-10. Ann Med Interne (Paris). 2002. PMID: 12518077 French.
Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.
Thiébaut R, Chêne G, Jacqmin-Gadda H, Morlat P, Mercié P, Dupon M, Neau D, Ramaroson H, Dabis F, Salamon R; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Thiébaut R, et al. Among authors: morlat p. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):380-6. doi: 10.1097/00126334-200307010-00013. J Acquir Immune Defic Syndr. 2003. PMID: 12843750
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.
Duval X, Journot V, Leport C, Chêne G, Dupon M, Cuzin L, May T, Morlat P, Waldner A, Salamon R, Raffi F; Antiprotease Cohort (APROCO) Study Group. Duval X, et al. Among authors: morlat p. Clin Infect Dis. 2004 Jul 15;39(2):248-55. doi: 10.1086/422141. Epub 2004 Jul 1. Clin Infect Dis. 2004. PMID: 15307035
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G; Mortality 2000 study group. Lewden C, et al. Among authors: morlat p. Int J Epidemiol. 2005 Feb;34(1):121-30. doi: 10.1093/ije/dyh307. Epub 2004 Nov 23. Int J Epidemiol. 2005. PMID: 15561752
461 results